Prolonged Exposure (PE) Treatment for Post Traumatic Stress Disorder (PTSD) 20 Minutes Versus 40 Minutes

PTSD Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00229307
• Other study ID #: SHEBA-05-3709-JZ-CTIL
• Status: Completed
• Phase: N/A
• First received: September 28, 2005
• Last updated: January 26, 2013
• Start date: December 2005
• Est. completion date: December 2010

Study information

• Verified date: January 2013
• Source: Sheba Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Israeli Health Ministry Pharmaceutical Administration
• Study type: Interventional

Clinical Trial Summary

Comparing the efficacy of 40 minutes PE treatment to 20 minutes of the same treatment

Recruitment information / eligibility

• Status: Completed
• Enrollment: 39
• Est. completion date: December 2010
• Est. primary completion date: December 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• PTSD

Exclusion Criteria:

• Psychotic symptoms

• Dissociation

• Drug or Alcohol dependence

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• PTSD
• Stress Disorders, Post-Traumatic
• Stress Disorders, Traumatic

Intervention

Behavioral:
• Prolonged Exposure (PE) therapy
20 minutes exposure
• Prolonged Exposure (PE) therapy
40 minutes exposure

Locations

Country	Name	City	State
Israel	Chaim Sheba Medical Center	Ramat-Gan

Sponsors (1)

Lead Sponsor	Collaborator
Sheba Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PSS-i		15 weeks and 1-year follow-up	No